Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Current Medicinal Chemistry
|
November 19, 2017
The Validation Path of Hypoxia PET Imaging: Focus on Brain Tumours
Natale Quartuccio, Marie-Claude Asselin
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
May 11, 2006
Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET
Andrew J Montgomery, Marie-Claude Asselin, Lars Farde, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
June 1, 2006
Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region
Marie-Claude Asselin, Andrew J Montgomery, Paul M Grasby, et al.
Physics in Medicine and Biology
|
July 11, 2002
In vivo metabolism and partitioning of 6-[18F]fluoro-L-meta-tyrosine in whole blood: a unified compartment model
Marie-Claude Asselin, Lindi M Wahl, Vincent J Cunningham, et al.
Physics in Medicine and Biology
|
April 24, 2004
Parametrically defined cerebral blood vessels as non-invasive blood input functions for brain PET studies
Marie-Claude Asselin, Vincent J Cunningham, Shigeko Amano, et al.
Molecular Nutrition & Food Research
|
November 19, 2015
Deferoxamine stimulates LDLR expression and LDL uptake in HepG2 cells
Johann Guillemot, Marie-Claude Asselin, Delia Susan-Resiga, et al.
Plos One
|
May 16, 2013
Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1)
Maryssa Canuel, Xiaowei Sun, Marie-Claude Asselin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2012
Quantifying heterogeneity in human tumours using MRI and PET
Marie-Claude Asselin, James P B O'Connor, Ronald Boellaard, et al.
The Journal of Biological Chemistry
|
January 7, 2011
Proprotein convertase PC7 enhances the activation of the EGF receptor pathway through processing of the EGF precursor
Estelle Rousselet, Suzanne Benjannet, Edwidge Marcinkiewicz, et al.
Hepatology (Baltimore, Md.)
|
June 3, 2009
PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression
Patrick Labonté, Syntia Begley, Carl Guévin, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Current Medicinal Chemistry
|
November 19, 2017
The Validation Path of Hypoxia PET Imaging: Focus on Brain Tumours
Natale Quartuccio, Marie-Claude Asselin
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
May 11, 2006
Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET
Andrew J Montgomery, Marie-Claude Asselin, Lars Farde, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
June 1, 2006
Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region
Marie-Claude Asselin, Andrew J Montgomery, Paul M Grasby, et al.
Physics in Medicine and Biology
|
July 11, 2002
In vivo metabolism and partitioning of 6-[18F]fluoro-L-meta-tyrosine in whole blood: a unified compartment model
Marie-Claude Asselin, Lindi M Wahl, Vincent J Cunningham, et al.
Physics in Medicine and Biology
|
April 24, 2004
Parametrically defined cerebral blood vessels as non-invasive blood input functions for brain PET studies
Marie-Claude Asselin, Vincent J Cunningham, Shigeko Amano, et al.
Molecular Nutrition & Food Research
|
November 19, 2015
Deferoxamine stimulates LDLR expression and LDL uptake in HepG2 cells
Johann Guillemot, Marie-Claude Asselin, Delia Susan-Resiga, et al.
Plos One
|
May 16, 2013
Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1)
Maryssa Canuel, Xiaowei Sun, Marie-Claude Asselin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2012
Quantifying heterogeneity in human tumours using MRI and PET
Marie-Claude Asselin, James P B O'Connor, Ronald Boellaard, et al.
The Journal of Biological Chemistry
|
January 7, 2011
Proprotein convertase PC7 enhances the activation of the EGF receptor pathway through processing of the EGF precursor
Estelle Rousselet, Suzanne Benjannet, Edwidge Marcinkiewicz, et al.
Hepatology (Baltimore, Md.)
|
June 3, 2009
PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression
Patrick Labonté, Syntia Begley, Carl Guévin, et al.
Page
of 6